The Post has sought comment from Truveta Research, and representatives for Mounjaro
But they work differently in ways that matter for planning
Consult a physician before using this product if you have been treated for, have been diagnosed with, or have a family history of any medical condition, or if you are taking any over-the-counter or prescription medication
For gastrointestinal symptoms commonly associated with GLP-1 therapy, research on specific strains (though not in GLP-1 users specifically) includes: Lactobacillus rhamnosus GG (ATCC 53103) has evidence for diarrhoea management Bifidobacterium lactis BB-12 and Bifidobacterium longum BB536 have been studied for constipation relief Lactobacillus plantarum 299v has some evidence for bloating and abdominal discomfort Colony-forming units (CFUs) indicate the number of viable bacteria per dose
Tirzepatide's dual mechanism allows for a higher dose ceiling because the GIP component modulates the gastrointestinal effects that would otherwise limit dosing
For those focused on weight management, this could be a critical factor